Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour

Journal of Drug Targeting

Volumn 12, Issue 7, 2004, Pages 443-451

  Harivardhan Reddy, L ^a   Sharma, R K ^b   Murthy, R S R ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Biodistribution; Doxorubicin; Gamma imaging; Poly(butyl cyanoacrylate) nanoparticles; Technetium 99m; Tumour delivery

Indexed keywords

CYANOACRYLATE DERIVATIVE; CYSTEINE; DOXORUBICIN; ENBUCRILATE; NANOPARTICLE; PENTETIC ACID; POLY(BUTYL CYANOACRYLATE); STANNOUS CHLORIDE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MIXTURE; DRUG PENETRATION; DRUG RETENTION; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; HUMAN; IN VITRO STUDY; INJECTION SITE; ISOTOPE LABELING; LYMPHOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE DISTRIBUTION; TUMOR REGRESSION; ZETA POTENTIAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHELATING AGENTS; CYANOACRYLATES; CYSTEINE; DOXORUBICIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GAMMA CAMERAS; LYMPHOMA; MICE; MICE, INBRED BALB C; MICROSPHERES; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; PENTETIC ACID; POLYMERS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 9444298454     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400011406     Document Type: Article

References (29)

1. Arulsudar, N., Subramanian, N., Mishra, P., Chuttani, K., Sharma, R.K. and Murthy, R.S.R. (2004) "Preparation, characterization and biodistribution of Technetium-99m-labeled leuprolide acetate-loaded liposomes in Ehrlich Ascites tumour bearing mice", AAPS Pharm Sci. 6, 1-13.
2. 99mTc-labeled liposome encapsulated cyclosporine", J. Drug Targeting. 11, 187-196.
3. Au, J.L.S., Jang, S.H., Zheng, J., Chen, C.T., Song, S., Hu, L. and Wientjes, M.G. (2001) "Determinants of drug delivery and transport to solid tumors", J. Control Release 74, 31-46.
4. Durand, R.E. (1989) "Distribution and activity of antineoplastic drugs in a tumour model", J. Natl. Cancer Inst. 81, 146-152.
5. Durand, R.E. (1990) "Slow penetration of anthracyclines into spheroids and tumours: atherapeutic advantage", Cancer Chemother. Pharmacol. 26, 198-204.
6. Harivardhan, R.L. and Murthy, R.S.R. (2003) "Polymerization of n-butyl cyanoacrylate in presence of surfactant: study of influence of polymerization factors on particle properties, drug loading and evaluation of its drug release kinetics", ARS Pharmaceutica 44 351-369.
7. Jain, R.K. (1996) "Delivery of molecular medicine to solid tumors", Science 271, 1079-1080.
8. Jain, R.K. (1994) "Barriers to drug delivery in solid tumors", Sci. Am. 271, 58-65.
9. Jain, R.K. (2001) "Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function", J. Control Release 74, 7-25.
10. Kabanov, A.V., Batrakova, E.V. and Alakbov, V.Y. (2002) "Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery", J. Control Release 82, 189-212.
11. Kreuter, J. (1983) "Physicochemical characterization of polyacrylic nanoparticles", Int. J. Pharm. 14, 43-58.
12. Kuh, H.J., Jang, S.H., Wientjes, M.G. and Au, J.L. (2000) "Computational model of intracellular pharmacokinetics of paclitaxel", J. Pharmacol. Exp. Ther. 293, 761-770.
13. Kuh, H.J., Jang, S.H., Wientjes, M.G., Weaver, J.R. and Au, J.L.S. (1999) "Determinants of paclitaxel penetration and accumulation in human solid tumour", J. Pharmacol. Exp. Ther. 290, 871-880.
14. Markman, M. (1998) "Intraperitoneal therapy of ovarian cancer", Semin.Oncol. 25, 356-360.
15. 99mTc-labeled 2-Iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies", Methods Find. Exp. Clin. Pharmacol. 24, 653-660.
16. Muranishi, S., Fujita, T., Murakami, M. and Yamamoto, A. (1997) "Potential for lymphatic targeting of peptides", J Control Release 46, 157-164.
17. Porter, C.J.H. (1997) "Drug delivery to the lymphatic system", Crit. Rev. Ther. Drug Carrier. Syst. 14, 333-393.
18. Reddy, L.H. and Murthy, R.S.R. (2004) "Influence of polymerization technique and experimental variables on particle properties and release kinetics of methotrexate from PBC nanoparticles", Acta Pharm., In Press.
19. 99mTc] technetium labeled liposomes in normal and tumour bearing rats", Biochem. Soc. Trans. 5, 290-291.
20. Rogers, W., Edlich, R.F. and Aust, J.G. (1960) "Tumour blood flow II Distribution of blood flow in experimental tumors", Angiology 20, 374-387.
21. Shrivastava, P., Singh, S.M. and Singh, N. (2003) "Effect of thymosinalpha1 on the production of nitric oxide by tumour-associated macrophages", Neoplasma 50, 47-50.
22. Song, D., Wientjes, M.G. and Au, J.L.S. (1997) "Bladder tissue pharmacokinetics of intravesical taxol", Cancer Chemother Pharmacol. 40, 285-292.
23. Subramanian, N., Arulsudar, N., Chuttani, K., Mishra, P., Sharma, R.K. and Murthy, R.S.R. (2003) "Radiolabeling, biodistribution and tumour imaging of stealth liposomes containing methotrexate", J. Alasbimn. 22(1-15), Article 6.
24. Takahashi, T. (1985) "Emulsion and activated carbon in chemotherapy", CRC Crit. Rev. Ther. Drug Carrier Syst. 2, 245-274.
25. Theobald, A.E. (1990) In: Sampson, C.B., ed, Text book of Radiopharmacy: Theory and Practice (Gordon and Breach, New York), pp 127-129.
26. Vauthier, C., Dubernet, C., Chauvierre, C., Brigger, I. and Couvreur, P. (2003) "Drug delivery to resistant tumours: the potential of poly(alkyl cyanoacrylate nanoparticles)", J. Control Release 93, 151-160.
27. Vigevani, A. and Williamson, M.J. (1980) "Doxorubicin", In: Florey, K., ed, Analytical profiles of drug substances (Academic press, New York), pp 245-274.
28. Vogelhuber, W., Spruâ, T., Bernhardt, G., Buschauer, A. and Gopferich, A. (2002) "Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts", Int. J. Pharm. 238, 111-121.
29. Yockman, J.W., Maheshwari, A., Han, S.oh. and Kim, S.W. (2003) "Tumour regression by repeated intratumoural delivery of water soluble lipopolymers p2CMVmIL-12 complexes", J. Control Release 87, 177-186.